Diginex's October Ballot: When a 77% Revenue Jump Gets Overshadowed by a 600 Million Share Question

Diginex revenue rose 77% to $3.6M, but a $1.05B Resulticks acquisition and 600M new shares dilute existing holders ahead of Oct. 8 vote.

On paper, Diginex just delivered the kind of growth number that typically commands a headline. Revenue for the fiscal year ending in March climbed 77 percent to $3.6 million, fueled by software and data sales alongside early contributions from acquired businesses Plan A, Matter, and The Remedy Project. The balance sheet carries no debt, and cash reserves sit at $4.9 million.

Yet the market barely blinked. The stock has been trading on a different story entirely — one that revolves around a transformative acquisition, a flood of new shares, and a shareholder vote that could redraw the company's ownership map.

The Deal That Rewrites the Register

The centerpiece is Resulticks, a takeover that has been restructured and re-announced, with the latest terms unveiled on a Wednesday. Under the revised agreement, Diginex would issue roughly 600 million new shares at $1.75 each, valuing the transaction at $1.05 billion. Existing Resulticks shareholders and incoming investors would collectively hold about 86 percent of the expanded share capital.

For current Diginex shareholders, the math is stark: dilution on a scale that reduces them to a minority position in their own company. The market's response has been measured but telling — an 8.7 percent decline since the revised terms went public.

The timeline is now locked in. An extraordinary general meeting is scheduled for October 8, where shareholders will vote on the updated purchase agreement dated August 14. The record date for voting eligibility was set at the close of trading in New York on that same day, with the transaction targeted for completion by October 30 at the latest. Anyone holding the stock now has roughly five weeks to decide the company's fate — and their own stake in it.

A Narrowing Window on Nasdaq

The contrast with late July is striking. Back then, Diginex received confirmation from Nasdaq that it had regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2), having closed at $1.00 or above for 20 consecutive trading days. It was a genuine milestone for a company that had been fighting to stay listed.

Weeks later, the stock trades at $1.20 — still above the threshold, but down 23 percent over the past 30 days alone. Friday brought another 3.2 percent decline, pushing the weekly loss to 6.2 percent. The market capitalization has shrunk to roughly €30 million, a figure that puts the scale of the proposed capital measure into perspective: a company this size is absorbing an acquisition that dwarfs its own valuation.

The pressure predates the Resulticks announcement. Roughly three weeks ago, Rhino Ventures disclosed a stake in Diginex — and since that filing, the shares have shed 30.8 percent. New capital found takers even as the price kept sliding, a dynamic that invites two readings: either genuine conviction in the long-term Resulticks story, or entry pricing that already discounts the coming dilution.

Insider Selling Complicates the Narrative

Just days before the vote, one of the company's most significant shareholders moved in the opposite direction. Director and ten-percent holder Miles Pelham sold 7,202,920 Diginex common shares at $1.00 each on August 17, with an additional 294,380 shares disposed of directly.

The scale of the transaction makes it the most conspicuous signal yet from inside the company's inner circle — arriving precisely as Diginex courts investors for a billion-dollar acquisition. Insider sales are not inherently a red flag, but unloading more than seven million shares in a single move, during a period of capital raising and structural transformation, raises questions about how much confidence those closest to the business have in the integration story.

The capital raise itself adds another layer. On August 17, Diginex announced a placement of 20 million new shares alongside an equal number of five-year warrants, priced at $1.00 per share, targeting more than $20 million in fresh funding.

Growth and Losses in Tandem

The latest financials provide context for the capital urgency. While revenue grew 77 percent, the net loss widened to $31.1 million — one source puts the figure at $31.2 million — with an adjusted EBITDA loss of $13.0 million and an operating loss of $24.9 million. Growth and losses expanding in lockstep is typical for young software firms, but it sharpens the question of how sustainable the standalone business model would be without Resulticks.

The company does point to $70 million in secured private financing commitments for the combined entity, and its debt-free status offers some cushion. But the structure of the deal — repeatedly delayed deadlines, a retroactively expanded share issuance, and a stock that has known only one direction for weeks — invites caution.

What October Holds

With a market capitalization of approximately €30.14 million and an RSI of 40.6, the stock sits in technically neutral territory, showing no clear oversold signal. The annualized volatility of 113 percent, however, underscores just how tense trading in the name has become.

Pelham's sale does not alter the fundamentals of the transaction itself, but it amplifies the question of whether insiders genuinely believe in the long-term payoff of the Resulticks merger. Until the October 8 vote, the stock remains a wager on the ballot's outcome. The real test comes after — when the company must prove that a deal this transformative can deliver on its promises to a shareholder base that will have been fundamentally redrawn.